Welcome to Jarrow Formulas

Supplier of Superior Nutritional Supplements

Jarrow Formulas Announces the Release of Jarro-Dophilus® Women.
LOS ANGELES – January 24, 2017 - Jarrow Formulas® announces its appointment as distributor of the Astarte® probiotic strains which the company will sell under its famous trademark “Jarro-Dophilus®” Women. This women-specific formula contains four clinically documented lactobacilli strains isolated from healthy women and supports urinary tract health and an optimal vaginal microflora.*

Astarte® is the only commercially available and clinically tested preparation which contains the documented strains found to be the most prevalent and dominant in the healthy vaginal microbiota of women: Lactobacillus crispatus, LbV 88, Lactobacillus jensenii, LbV 116, Lactobacillus gasseri, LbV 150N, Lactobacillus rhamnosus, LbV 96.

Available in two strengths, the Jarro-Dophilus® Women 5 Billion Formula is shelf stable and features Jarrow Formulas’ new pH-Sensitive Food Grade Enteric Coating on veggie capsules. The 10 Billion Formula requires refrigeration and uses non-coated gelatin capsules. Both formulas guarantee their potency until the date of expiration to provide an assurance to consumers they get the probiotic quantities stated on the label. Each formula is available in 30 and 60 count.

Probiotic supplements benefit from proper packaging and Jarro-Dophilus ® Women features superior stability due to individually sealed aluminum-aluminum units that are blister packed to provide an airtight and moisture resistant atmosphere for each capsule.

Jarrow Rogovin, the company's president, explained, "Just adding cranberry extract or other such ingredients does not turn a standard probiotic blend into a women's formula. Jarro-Dophilus Women is unique, consisting of the dominant bacteria species of the healthy vaginal microflora and isolated from healthy, pregnant women. Importantly, these strains will colonize and provide a healthy flora in the event of microbial imbalance. Only the four Astarte strains can make this claim. They have been clinically tested with positive results and more studies are on the way to further support what is absolutely the best probiotic product for women in the world!"

"Years of research and development have gone into finding the perfect strains for a women's probiotic supplement,” says Helmut Essl, CEO of HSO Health Care GmbH. "Our partnership with Jarrow Formulas provided support during the initial strain development process and continues with ongoing research projects. We are proud to distribute our Astarte probiotic strains in partnership with Jarrow Formulas' “Jarro-Dophilus” brand."

Jarro-Dophilus® Women clinically tested Astarte® strains are protected by European Patent 2,509,610 and U.S. Patent 8,846,027. Astarte® is owned by HSO Health Care GmbH, Vienna, Austria, and licensed in the U.S. to Jarrow Formulas, Inc. Other international patents pending.



Jarrow Formulas products can be found at fine health shops and vitamin stores nationwide. For more   information, please visit www.jarrow.com.

ABOUT JARROW FORMULAS

Jarrow Formulas is based in Los Angeles, California, and is a formulator and supplier of superior   nutritional supplements. The company was founded in 1977 and today it markets its products in the   United States and throughout the world. Jarrow Formulas' goal is to promote optimal health based on sound scientific research data. The company’s complete line of nutritional products includes vitamins, minerals, probiotics, standardized herbal concentrates, amino acids, enzymes and enteral nutrition products. www.jarrow.com.

JARROW FORMULAS, INC. MEDIA CONTACT:

Sky Garmon, Marketing Associate, Jarrow Formulas

(310) 736-3136

sky@jarrow.com

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.